孕中期子痫前期和/或胎儿生长受限妊娠中的胎儿心脏重塑:基于人群数据的深度学习方法
丹麦全国回顾性队列研究纳入139430例自然受孕单胎,用人工智能模型在18-22周常规筛查超声图像上自动分割提取胎儿心脏生物测量。与参考组相比,子痫前期(PE)伴适龄胎儿的胎儿右侧心脏结构显著增大、主肺动脉和室间隔更宽;血压正常伴胎儿生长受限(FGR)的胎儿心脏结构显著更小、左心室球形度增加;PE合并FGR的胎儿仅左心房面积更小、升主动脉更窄、左心室球形度增加,但与血压正常合并FGR的胎儿相比主肺动脉和室间隔更宽、右侧结构更大。结论认为心脏重塑在孕中期即已显现,PE与FGR的调控模式不同,PE与右心增大和主肺动脉直径增大相关。
要点
- 孕中期PE伴适龄胎儿的右侧心脏结构显著大于参考组,主肺动脉和室间隔更宽。
- 孕中期血压正常伴FGR的胎儿心脏结构显著更小,主肺动脉和升主动脉直径更小,左心室球形度增加。
- PE合并FGR的胎儿与血压正常合并FGR的胎儿相比主肺动脉和室间隔更宽、右侧结构更大,提示PE对胎儿心脏重塑有独立效应。
核心结论
- 胎儿心脏重塑在孕中期即可显现,PE与FGR对胎儿心脏形态的调控模式不同;PE与右心增大和主肺动脉直径增大相关。
研究设计与样本
- 丹麦全国回顾性队列研究,纳入139430例自然受孕单胎,于孕18-22周常规筛查时获取至少一个标准化心脏切面(四腔心切面和/或三血管切面)的超声图像。
- 采用人工智能模型自动分割并提取胎儿心脏生物测量,差异以校正孕中期腹围后的Z评分表示。
- 分为四组:参考组为血压正常妊娠的适龄胎儿(n=131150);PE+AGA组为PE妊娠的适龄胎儿(n=3095);血压正常+FGR组为血压正常妊娠的FGR胎儿(n=4572);PE+FGR组为PE妊娠的FGR胎儿(n=613)。
主要发现
- 与参考组相比,PE+AGA组胎儿右侧心脏结构显著更大,主肺动脉和室间隔更宽。
- 与参考组相比,血压正常+FGR组胎儿心脏结构显著更小,包括主肺动脉和升主动脉直径更小,左心室球形度增加。
- 与参考组相比,PE+FGR组胎儿仅左心房面积更小、升主动脉更窄、左心室球形度增加。
- 与血压正常+FGR组相比,PE+FGR组胎儿主肺动脉和室间隔显著更宽、右侧结构更大,表现类似PE+AGA组。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pre-eclampsia (PE) and fetal growth restriction (FGR) have been shown to impact fetal cardiac remodeling in the third trimester and postnatally, with evidence to suggest that this leads to increased long-term cardiovascular risk. This study aimed to examine fetal cardiac remodeling in pregnancies with PE and/or FGR during the second trimester. METHODS: This was a retrospective nationwide cohort study of ultrasound images from routine screening at 18-22 weeks of gestation in Denmark. We included 139 430 singleton pregnancies that were conceived spontaneously for which at least one relevant standardized cardiac plane (four-chamber view and/or three-vessel view) was available from the second-trimester scan. An artificial intelligence model performed automated segmentation and extraction of fetal cardiac biometric measurements. Data were collected for four groups: the reference group, defined as appropriate-for-gestational-age (AGA) fetuses from a normotensive pregnancy (n = 131 150); AGA fetuses from a PE pregnancy (AGA + PE group; n = 3095); FGR fetuses from a normotensive pregnancy (normotensive + FGR group; n = 4572); and FGR fetuses from a PE pregnancy (PE + FGR group; n = 613). Differences between groups in cardiac biometric measurements were presented as Z-scores adjusted for abdominal circumference at the second-trimester scan. RESULTS: Compared with the reference group, fetuses in the PE + AGA group had significantly larger right-sided heart structures, and the main pulmonary artery (MPA) and ventricular septum were wider. Fetuses in the normotensive + FGR group displayed significantly smaller cardiac structures, including smaller MPA and ascending aorta diameters, and increased left ventricular sphericity compared with the reference group. Fetuses in the PE + FGR group differed significantly from the reference group only in terms of smaller left atrial area, narrower ascending aorta and increased left ventricular sphericity. However, PE + FGR fetuses had significantly wider MPA and ventricular septum and larger right-sided structures compared with normotensive + FGR fetuses, mimicking the features of the PE + AGA group, suggesting a distinct effect of PE on fetal cardiac remodeling. CONCLUSIONS: Cardiac remodeling is evident as early as the second trimester, with distinct patterns of modulation in fetuses from pregnancies affected by PE vs FGR. In particular, PE is associated with an enlarged right heart and greater MPA diameter. Understanding these early differences in fetal cardiac morphology may improve risk prediction models and guide early intervention to improve long-term cardiovascular outcome. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Taksøe-Vester CA, Mikolaj K, Petersen OB, et al. Fetal cardiac remodeling in second trimester in pregnancies with pre-eclampsia and/or fetal growth restriction: deep-learning-based approach using population-wide data. Ultrasound Obstet Gynecol. 2025. PMID: 41164991. doi:10.1002/uog.70123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。